Covid-19 has changed how research is done; will the changes be permanent?

In the case of Covid, researchers, drug companies and regulators are trying to compress that timeline as far as possible

A crisis can trigger major transformations. The race for a Covid-19 cure has also dramatically altered the way drug and vaccine research, clinical trials, and drug production is done globally. The urgency has led to partnerships and alliances between erstwhile rivals; unprecedented levels of government-private co-operation; and production capacities being built even before a drug or a vaccine is ready. It has also led to a shift in priorities for drug research companies as they put aside other research projects to focus on a Covid-19 cure. India finds itself in the thick of action because of its production capabilities primarily,